Neuropathic joints.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 4569622)

Published in Semin Arthritis Rheum on January 01, 1972

Authors

F E Bruckner, A Howell

Articles by these authors

(truncated to the top 100)

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer (2003) 5.10

Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J (2001) 3.56

An in vitro method for assessing the plaque forming ability of oral bacteria. Arch Oral Biol (1967) 3.11

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet (2004) 3.10

Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94

A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer (2004) 2.87

Familial breast cancer. BMJ (1994) 2.54

Uptake of screening and prevention in women at very high risk of breast cancer. Lancet (2001) 2.45

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39

Perception of risk in women with a family history of breast cancer. Br J Cancer (1993) 2.32

The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology (1995) 2.27

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24

Cytogenetic and scanning study of patients receiving intra-articular injections of gold-198 and yttrium-90. Ann Rheum Dis (1973) 1.93

High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat (2001) 1.88

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat (1999) 1.84

Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer (1991) 1.83

Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer (2007) 1.80

Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79

The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer (2001) 1.70

Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms. Lancet (1983) 1.69

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer. Eur J Cancer (1996) 1.67

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 1.65

The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61

The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer (1984) 1.61

Odontomyces viscosus, gen. nov., spec. nov., a filamentous microorganism isolated from periodontal plaque in hamsters. Sabouraudia (1965) 1.61

Association between prolonged dietary vitamin D deficiency and autonomous hyperparathyroidism. BMJ (1989) 1.58

Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst (1997) 1.58

Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol (2007) 1.57

Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56

Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia (1998) 1.52

A filamentous microorganism isolated from periodontal plaque in hamsters. 1. Isolation, morphology and general cultural characteristics. Sabouraudia (1963) 1.52

High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial. Ann Oncol (2005) 1.51

Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol (1996) 1.49

Can hair be used to screen for breast cancer? J Med Genet (2000) 1.49

A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther (2000) 1.45

Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44

Screening by mammography, women with a family history of breast cancer. Eur J Cancer (1998) 1.44

Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med (1986) 1.44

Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43

Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43

Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) (1994) 1.42

Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42

The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer (1988) 1.42

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group. Cancer (1998) 1.41

An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2004) 1.39

Effect of clothing on dispersal of Staphylococcus aureus by males and females. Lancet (1974) 1.39

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A (1989) 1.38

Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer (1993) 1.36

Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35

A filamentous microorganism isolated from periodontal plaque in hamsters. II. Physiological and biochemical characteristics. Sabouraudia (1963) 1.34

Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology (1999) 1.32

Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet (1986) 1.30

Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet (2001) 1.28

Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer (1994) 1.28

Carcinomatous meningitis in solid tumours. Ann Oncol (1996) 1.27

Histological detection of oestrogen receptor in human breast carcinomas. Lancet (1980) 1.26

A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. Br J Cancer (1984) 1.25

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25

Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer (2006) 1.24

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet (2011) 1.23

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma. BMJ (1988) 1.23

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer. J Clin Oncol (1986) 1.22

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer (1991) 1.21

Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int J Cancer (1991) 1.21

The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer (1988) 1.19

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet (2009) 1.18

Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet (1984) 1.18

Objective measurement of therapeutic response in breast cancer using tumour markers. Br J Cancer (1991) 1.18

The effects of drugs that cause neutropenia upon colony formation by bone marrow cells in semi-solid agar. Clin Sci Mol Med (1974) 1.17

Expression of ykdA, encoding a Bacillus subtilis homologue of HtrA, is heat shock inducible and negatively autoregulated. J Bacteriol (2000) 1.17

Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant. Cancer (1994) 1.16

Leucocyte migration inhibition with aggregated gamma globulin in patients with rheumatoid arthritis. Clin Exp Immunol (1973) 1.16

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life. Eur J Cancer (1992) 1.16

Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry (1970) 1.15

Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res (1992) 1.14

Tumour markers in breast cancer. Br J Cancer (1979) 1.13

Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials. J Clin Oncol (2001) 1.12

Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet (2008) 1.12

Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis. Genes Chromosomes Cancer (1995) 1.12

YkdA and YvtA, HtrA-like serine proteases in Bacillus subtilis, engage in negative autoregulation and reciprocal cross-regulation of ykdA and yvtA gene expression. J Bacteriol (2001) 1.12

Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis (1993) 1.11

Serotypes of Cryptococcus neoformans in patients with AIDS. J Infect Dis (1986) 1.11

A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. Eur J Cancer (1995) 1.11

Effect of protein binding on levels of ampicillin and cloxacillin in synovial fluid. Clin Pharmacol Ther (1972) 1.11

Depression of bone marrow colony formation in gold-induced neutropenia. Br Med J (1975) 1.11

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. Br J Cancer (1993) 1.10

Von Recklinghausen's disease in children. Plast Reconstr Surg (1972) 1.09

Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat (2004) 1.09

Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro. Lancet (1987) 1.09

Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. Eur J Cancer (1991) 1.08

Production of an extracellular levan by Odontomyces viscosus. Arch Oral Biol (1967) 1.08

Frozen shoulder. J R Soc Med (1983) 1.07

Birmingham Medical Research Expeditionary Society 1977 Expedition: the diuresis and related changes during a trek to high altitude. Postgrad Med J (1979) 1.07

Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol (1992) 1.07

Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression. Breast Cancer Res Treat (1997) 1.07

Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen? Br J Cancer (2006) 1.06